- WP Carey reported an AFFO (Adjusted Funds From Operations) per share of $1.17 for the second quarter of 2024.
- Total revenue for the period was $389.7 million.
- WP Carey has revised its 2024 AFFO guidance to a range of $4.63 to $4.73 per diluted share.
- The revision is based on an anticipated full-year investment volume between $1.25 billion and $1.75 billion.
- Analyst recommendations include: 2 buys, 10 holds, and 2 sells.
A look at Wp Carey Inc Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
WP Carey Inc., a global net-lease REIT specializing in sale-leaseback and build-to-suit financing solutions, is positioned favorably for the long-term based on a comprehensive analysis using Smartkarma Smart Scores. With a high score in Dividend and Value, the company is esteemed for its stable dividend payouts and attractive valuation relative to its peers. This indicates a positive outlook for income-seeking investors looking for consistent returns.
Although WP Carey Inc. shows strength in Dividend and Value, the scores for Growth, Resilience, and Momentum are relatively lower. While the company may not exhibit strong growth potential or resilience against economic downturns, its solid fundamentals in dividend and value aspects suggest a steady and reliable performance in the long run. Investors seeking income and value stability may find WP Carey Inc. to be a promising addition to their portfolios.
### WP Carey Inc. is a global net-lease REIT that provides long-term sale-leaseback and build-to-suit financing solutions for companies worldwide. In addition to its owned portfolio of diversified global real estate, W. P. Carey manages a series of non-traded REITs. ###
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
